Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Gastric tuberculosis in an elderly patient:a case report].
Kano Y, Yamamoto H, Naito T, Yamada M, Matsubara H, Sakamaki K, Maeda M, Ohashi S, Urano F. Kano Y, et al. Among authors: yamamoto h. Nihon Shokakibyo Gakkai Zasshi. 2018;115(11):985-995. doi: 10.11405/nisshoshi.115.985. Nihon Shokakibyo Gakkai Zasshi. 2018. PMID: 30416160 Japanese.
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
[EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
Fukunaga A, Morita E, Miyagi T, Eto K, Shimizu A, Kagami S, Yamamoto H, Vardi M, Tang Y, Wang Y, Hide M. Fukunaga A, et al. Among authors: yamamoto h. Arerugi. 2020;69(3):192-203. doi: 10.15036/arerugi.69.192. Arerugi. 2020. PMID: 32435020 Clinical Trial. Japanese.
Role and prognostic value of growth differentiation factor 15 in patient of heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF registry.
Sakamoto D, Matsuoka Y, Nakatani D, Okada K, Sunaga A, Kida H, Sato T, Kitamura T, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yasumura Y, Yamada T, Hikoso S, Sotomi Y, Sakata Y; OCVC-Heart Failure Investigators. Sakamoto D, et al. Open Heart. 2025 Jan 19;12(1):e003008. doi: 10.1136/openhrt-2024-003008. Open Heart. 2025. PMID: 39832941
10,280 results
You have reached the last available page of results. Please see the User Guide for more information.